Off-Label GLP-1 Prescribing: What It Means (and What It Doesn't)

Off-label GLP-1 prescribing means a clinician prescribes an FDA-approved medicine for a use, age group or dose that is not listed on its official label, such as prescribing Ozempic, which is approved for type 2 diabetes, to someone without diabetes for weight loss. It is legal and common in medicine, but FDA has not reviewed whether the drug is safe and effective for that particular use.

That last bit is the whole point. Off-label is not "illegal" and it is not "unapproved drug." It is "approved drug, unreviewed use."

What does FDA actually say about off-label use?

FDA's patient page calls it "unapproved use of an approved drug." It gives three common forms: using a drug for a condition it is not approved to treat, giving it a different way, or giving it at a different dose. Health care providers generally may prescribe a drug for an unapproved use when they judge it medically appropriate for the patient. FDA also notes that, for the unapproved use, it "has not determined that the drug is safe and effective."

Common reasons for off-label prescribing include having no approved option for a condition, or approved options not working for that person.

Real GLP-1 examples: on-label vs off-label

Labels change, so this table reflects the prescribing information on DailyMed as of October 2026. Always check the current version (here's how).

Medicine	What the label covers (summary)	Examples that would be off-label
Ozempic (semaglutide injection)	Adults with type 2 diabetes: blood sugar control, lowering heart event risk with heart disease, and lowering kidney/heart risk with chronic kidney disease	Weight loss in someone without type 2 diabetes
Wegovy injection (semaglutide)	Lowering heart event risk in adults with heart disease and obesity or overweight; long-term weight reduction in adults and children 12+ with obesity (adults with overweight plus a related condition); MASH with moderate to advanced fibrosis in adults (accelerated approval)	Use in children under 12
Wegovy tablets	Heart event risk reduction and long-term weight reduction in adults	Use in anyone under 18
Mounjaro (tirzepatide)	Type 2 diabetes in adults and children 10+; lowering heart event risk in adults with type 2 diabetes at high risk	Weight loss in someone without type 2 diabetes
Zepbound (tirzepatide)	Long-term weight reduction in adults with obesity, or overweight plus a related condition; moderate to severe obstructive sleep apnea in adults with obesity	Use in anyone under 18

Notice something funny? The same molecule can be on-label under one brand and off-label under another. Semaglutide for weight management is on-label as Wegovy and off-label as Ozempic. Tirzepatide for weight is on-label as Zepbound and off-label as Mounjaro. Same active ingredient, different approved uses, different labels, and sometimes very different insurance treatment.

What else counts as off-label?

Off-label is not only about the condition. Using an approved product in a way the label does not describe also counts, for example:

• A dosing schedule not on the label. Tiny doses, stretched intervals or skipped titration steps. Social media calls some of this "microdosing"; see what the evidence says about GLP-1 microdosing.
• Combinations the label advises against. The Wegovy and Zepbound labels both say using them with other semaglutide or tirzepatide products, or with any other GLP-1 receptor agonist, is not recommended.

Off-label is not the same as unapproved

This is where headlines and ads blur things, so here is the clean version:

Category	Is the product FDA-approved?	Example
On-label	Yes, for this use	Zepbound for an adult with obesity
Off-label	Yes, but not for this use, age or dose	Ozempic prescribed for weight loss without diabetes
Compounded	No. Compounded drugs do not go through FDA premarket review	Compounded semaglutide from a pharmacy
"Research use only"	No. Not for human use at all	Peptide vials sold online "for research"

An off-label prescription still involves a real, FDA-approved product with a known manufacturer, quality controls and a label full of safety information. Compounded and research-use products skip some or all of that. FDA's July 2024 alert on compounded semaglutide described overdoses of 5 to 20 times the intended dose, partly from confusing "units" and milliliters. That is a very different risk picture from an approved pen used off-label. See compounded GLP-1 red flags and why "research use only" matters.

Does insurance cover off-label GLP-1 prescriptions?

Often not, and this is where off-label gets practical. Plans usually tie coverage to approved or "medically accepted" uses. Medicare Part D, for example, generally covers drugs for a "medically accepted indication," which CMS's Part D manual defines as an FDA-labeled indication or one supported by citation in recognized drug compendia (AHFS or DRUGDEX). Commercial plans set their own rules, and a prior authorization for a diabetes medicine may ask your prescriber to document the diabetes diagnosis. So an off-label prescription might be completely legal and still land you with the full cash price. Check before you fill. (Reading a formulary for GLP-1 medicines.)

What to ask your prescriber about off-label use

FDA suggests a few questions, and we added two:

• "What is this drug approved for?"
• "What studies support using it for my situation?"
• "Are there approved options, and how do the benefits and risks compare?"
• "How will we monitor whether it is working and safe?"
• "Will my insurance cover it for this use?"

A good answer is specific to you. It is not "everybody's doing it." If you go ahead, keeping a log of doses and side effects (GLPily has a shot and pill log with reminders) gives you and your prescriber something concrete to review at follow-up.

Common questions

Is taking Ozempic for weight loss off-label?

Yes, if you do not have type 2 diabetes. Ozempic's label covers adults with type 2 diabetes. Semaglutide is approved for weight management under the brand Wegovy.

Is off-label prescribing legal?

Yes. Clinicians may generally prescribe approved drugs for unapproved uses when they judge it medically appropriate.

Is off-label the same as compounded?

No. Off-label uses an FDA-approved product. Compounded drugs are not FDA-approved and do not undergo FDA premarket review of safety, effectiveness or quality.

Is Zepbound approved for teenagers?

As of October 2026, the Zepbound label covers adults only. Wegovy injection's weight indication includes children 12 and older with obesity.